Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults

NCT03065309 is registered in ClinicalTrials.gov with Brasilia University Hospital as lead sponsor.

NCT NCT03065309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03065309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults
Lead sponsor
Brasilia University Hospital
Phase
Phase 3
Overall status
Completed
Start date
February 25, 2017
Completion date
March 1, 2017
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bradycardia, hypotension